FormWeb • bupivacaine liposome

Huntsville Hospital

Approved Hospital Formulary

Suggestions or Corrections? Above and Beyond Nominations Formulary Request

Add Formweb to your mobile device

Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.

Huntsville Hospital

Approved Hospital Formulary

Suggestions or Corrections? Above and Beyond Nominations Formulary Request

Search results for:

bupivacaine liposome

bupivacaine liposome

Non-formulary Miscellaneous Program Formulary

Drug Name	Form	Strength	Formulary Unrestricted	Formulary Restricted	Non-Formulary	Interchange
Exparel	SUSPENSION, INJECTABLE	1.3% (13.3 mg/mL)

VIEW MORE Local Anesthetics
CLASS

Comments:

EXAPREL was reclassified as Non-Formulary effective January 1, 2019.

Reviewed: February 26, 2013 (Plastic Surgery), and July 23, 2013, and November 19, 2013, and September 23, 2014 (Colorectal Surgery), and 24 May 2016 (Bariatric Surgery), and 25 April 2017 (Thoracotomy cases), and 23 Oct 2018 (Exparel formulary update)

Last updated: Jan. 3, 2019

This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.